Need help? Email us or call 919-549-8880.
Results
Your search returned 34 companies:
| Alaeras Inc. | Alaeras specializes in design and manufacturing of drug delivery products. The company is currently developing a platform technology for dry powder nasal vaccines that do not require refrigeration. | Cary |
| AlphaVax Inc. | AlphaVax is a clinical-stage company focused on developing new vaccine products for infectious diseases, biodefense and cancer. The AlphaVax in-house product pipeline includes products for Herpes Simplex virus, influenza and Respiratory Syncytial Virus. | Research Triangle Park |
| Alphavax Inc. (Lenoir) | AlphaVax's GMP manufacturing facility in Lenoir is leased from Greer Laboratories. The vaccine production facility is a BSL-3. | Lenoir |
| Arbovax Inc. | Arbovax Inc. is an early stage company focused on commercialization of a novel technology to develop improved vaccines to prevent arthropod-borne diseases. | Raleigh |
| Argos Therapeutics Inc. | Argos Therapeutics is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. | Durham |
| Biogen Idec | Biogen Idec is a global company focused on the discovery, development, manufacturing & commercialization of therapies in areas of high unmet medical needs. Biogen Idec operates a large scale manufacturing facility and customer service center in RTP. | Research Triangle Park |
| Catalent Pharma Solutions | Catalent's Morrisville site provides analytical testing and other scientific services. This facility is Catalent's primary location for inhalation product development. | Research Triangle Park |
| Cirrus Pharmaceuticals Inc. | Cirrus Pharmaceuticals provides pharmaceutical product development services, including physical and chemical characterization, formulation development, stability testing, process development, as well as scale-up and technical transfer to manufacturing. | Research Triangle Park |
| ClinWorks Inc. | ClinWorks conducts Phase I and Phase II oncology trials for pharmaceutical and biotech companies. | Charlotte |
| Diosynth Biotechnology Inc. (RTP) | Diosynth Biotechnology, a part of Schering-Plough Corporation, provides contract biopharmaceutical development and cGMP manufacturing services. The RTP location is Diosynth's manufacturing facilities site. | Morrisville |
| Family Health International | Family Health International is working worldwide to address comprehensive health issues in resource-poor settings. The company is developing strategies to respond to HIV/AIDS, other sexually transmitted infections and reproductive health concerns. | Research Triangle Park |
| GlaxoSmithKline (RTP) | GlaxoSmithKline is a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology and vaccines products. The RTP site is the US headquarters. | Research Triangle Park |
| Global Vaccines Inc. | Global Vaccines is a nonprofit company that develops high-tech vaccines for developing countries to prevent diseases such as HIV/AIDS, dengue fever, malaria, and viral diarrhea. | Research Triangle Park |
| Goldsboro Laboratories LLC | Goldsboro Laboratories develops vaccines for the swine, poultry and cattle divisions of Goldsboro Milling Company. | Goldsboro |
| Greer Laboratories Inc. | Greer Laboratories develops and provides allergy immunotherapy products and services for treating humans and animals. | Lenoir |
| Happy Jack Inc. | Happy Jack manufactures insecticides and pharmaceutical preparations for the treatment of dogs. | Snow Hill |
| ImmunoBiosciences Inc. | ImmunoBiosciences develops immune complex vaccines for human and veterinary use. | Raleigh |
| Liquidia Technologies Inc. | Liquidia Technologies utilizes its proprietary PRINT platform to design, develop, and manufacture precisely engineered particles and films for applications in engineered drug therapies and optical films. | Research Triangle Park |
| Max Neeman International Inc. | Max Neeman is an ISO certified, India-based CRO with U.S. business development office in Cary and headquarters in New Delhi. Operational since 2001, their services include site management, data management and monitoring for Phase I-IV clinical trials. | Cary |
| Meade Biologics LLC | Meade Biologics provides consulting services related to the manufacturing, testing and regulation of vaccines and biologics. Areas of specialization include clinical immunoassays, bioassays and potency tests. | Hillsborough |
| Merck & Co. Inc. (Durham) | Merck's facility in Durham will produce two vaccines – one for chicken pox and the other for measles, mumps and rubella. The first vaccines from the plant should be available by 2009. | Durham |
| Natural Products & Glycotechnology Research Institute Inc. | The Natural Products and Glycotechnology Research Institute is developing new methods for the synthesis of oligosaccharides, so the molecules can be used in the development of vaccines or diagnostic tools. | Pittsboro |
| Novartis Vaccines and Diagnostics Inc. | Novartis' plant in Holly Springs will produce up to 50 million doses of seasonal trivalent flu vaccines. The plant is slated to open in 2010. | Holly Springs |
| Peptagen Inc. | Peptagen Inc. is a small biotechnology company that is developing cytotoxic T-lymphocyte (CTL) vaccine products for the prevention and treatment of pathogenic diseases and cancer. | Raleigh |
| Pfizer Inc. (RTP) | Pfizer's RTP location is an extension of their vaccine production plant in Sanford. | Morrisville |
| Pfizer Inc. (Sanford) | Pfizer's Sanford facility develops and manufactures pediatric vaccines such as Prevnar and Meningitec. | Sanford |
| Pfizer Poultry Health | Pfizer Poultry Health develops and manufactures systems for in-ovo vaccination of poultry. | Research Triangle Park |
| Pique Therapeutics Inc. | Pique Therapeutics is developing new therapeutics for cancer. The company's lead product (PT 107) is a therapeutic vaccine to treat non-small cell lung cancer (NSCLC), and is in Phase 2 clinical trials. | Durham |
| Prima Tech USA | Prima Tech USA develops, manufactures and markets products for the animal health industry, including animal health vaccinators, bottle holders for animal vaccines, artificial insemination catheters and animal livestock markers. | Kenansville |
| SoyMeds Inc. | Soymeds is a biotechnology company focused on the development and validation of soy seed-based therapeutics that can be used to treat, prevent, cure and diagnose disease. | Davidson |
| Synergy Vaccines Inc. | Synergy Vaccines is a biopharmaceutical company engaged in the research, development, and commercialization of novel vaccines using SynerVax™ adjuvant technology. | Raleigh |
| Talecris Biotherapeutics | Talecris Biotherapeutics discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology and hemostasis. | Research Triangle Park |
| Triangle Research Solutions Inc. | Triangle Research Solutions provides clinical trial services such as project management, AE/SAE monitoring, CRF design, IVRS consultation, site recruitment, patient recruitment, and protocol consultation. | Hillsborough |
| V-Bio Inc. | V-Bio provides testing in support of the development of vaccines and/or drugs. V-Bio provides testing that isn't widely available, as well as antibody assays needed to advance clinical research trials involved with vaccine and/or drug development. | Charlotte |
Need help? Email us or call 919-549-8880.
The North Carolina Biotechnology Center strives to provide accurate and current data on the bioscience community in North Carolina. You may reproduce the site content for any legal purpose with proper attribution. Attribution shall take the following form: "Data provided by the North Carolina Biotechnology Center, www.ncbiotech.org."